AFR: Quadrant Growth Fund dealmaker invests in fast-growing medtech

Date: August 26, 2024

Source: Australian Financial Review

‍

Excerpt

Quadrant Private Equity partner Johnny Zhang has agreed terms to invest in Evolution Surgical, a designer and manufacturer of spinal implants.

Quadrant is investing in the business through its $530 million Growth Fund 2 and will partner with Evolution chief executive Jack Lancaster and management. Evolution’s portfolio of products includes everything from spinal implants to biologics for patients with spinal tumours, deformity, trauma, or degenerative disc disease.

‍

To read full article, click here.

‍